P
Pioneer Gene Technology (Hangzhou)
Innovative digital PCR solutions for precise DNA/RNA quantification and pathogen detection
About Pioneer Gene Technology (Hangzhou)
PilotGene is a biotechnology company specializing in digital PCR (Polymerase Chain Reaction) technology, which is used for the absolute quantification of DNA and RNA molecules. The company has developed a proprietary chip, the DG32 digital PCR sampler, which allows for rapid preparation and generation of digital PCR samples. This technology is particularly advantageous for its high accuracy and sensitivity in detecting target DNA or RNA molecules. PilotGene serves clients in the healthcare, research, and diagnostics sectors, providing solutions for the detection of pathogenic microorganisms. The company operates in the biotechnology market, focusing on innovations that enhance the precision and efficiency of molecular diagnostics. PilotGene generates revenue through the sale of its digital PCR systems and related consumables, as well as through service contracts for specialized diagnostic solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 21.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Sep 2023 | $14M | $55M | Simiao Capital · Huzhou Chenxiang Equity Investment Partnership | ↗ |
| SERIES AEquity / VC | Aug 2021 | $17M | $66M | Fortune Venture | ↗ |
Growth signals
Latest recorded traffic for Pioneer Gene Technology (Hangzhou) is 20 monthly website visits, down 98.2% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pioneer Gene Technology (Hangzhou) in the Hangzhou ecosystem
The Pioneer Gene Technology (Hangzhou) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Fortune Venture- SCSimiao Capital
- HPHuzhou Chenxiang Equity Investment Partnership
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pioneer Gene Technology (Hangzhou) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pioneer Gene Technology (Hangzhou)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








